Geoffrey Nichol

Geoffrey M.
Nichol is currently Director at TempestTx, Inc. and Non-Executive Director at HaemaLogiX Pty Ltd. since 2022.
Former roles include Independent Director at Tempest Therapeutics, Inc. from 2019 to 2026, Director-Group Medical Clinical Development at GlaxoSmithKline LLC from 1989 to 1996, Senior Vice President-Product Development at Medarex, Inc. from 2002 to 2009, Chief Medical Officer & Senior Vice President at BioMarin Pharmaceutical, Inc. from 2016 to 2021, Executive Vice President-Research & Development at Sangamo Therapeutics, Inc. from 2011 to 2016, Clinical Research Physician at GSK Plc from 1989 to 1996, and VP-Global Project & Portfolio Management at Novartis Pharmaceuticals Corp.
from 1996 to 2002.
Other former positions include Independent Director at Millendo Therapeutics, Inc., Chief Medical Officer at Ikaria, Inc., and Senior Vice President-Development at AbCellera Biologics, Inc. Education includes an MBA from the University of Warwick and undergraduate and doctorate degrees from Otago Medical School.